<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 4: Inflammation Control: Evidence for Dietary & Lifestyle Interventions | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 28px;
}
.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
 font-weight: 700;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper { padding: 0 16px 60px 16px; }
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 24px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 19: L2: Research & Evidence</span>
 <h1 class="lesson-title">Inflammation Control: Evidence for Dietary & Lifestyle Interventions</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üí° Evidence-Based Practice</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#inflammatory-cascade"><span class="section-num">01</span>The Inflammatory Cascade</a></li>
 <li><a href="#aip-evidence"><span class="section-num">02</span>The AIP Diet: Clinical Evidence</a></li>
 <li><a href="#gluten-thyroid"><span class="section-num">03</span>Gluten & Molecular Mimicry</a></li>
 <li><a href="#ldn-research"><span class="section-num">04</span>The LDN Frontier</a></li>
 <li><a href="#clinical-translation"><span class="section-num">05</span>Clinical Protocol Translation</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In previous lessons, we explored the <strong>Gut-Thyroid-Immune Axis</strong>. Now, we bridge that theory into practice by examining the specific <strong>clinical evidence</strong> for interventions that extinguish the inflammatory fire and restore thyroid sensitivity.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Specialist. As we dive into the research surrounding inflammation control, remember that your role is to translate high-level science into life-changing results for your clients. Many of the women you will serve‚Äîambitious, high-achieving professionals‚Äîare often told their labs are "normal" while they suffer from systemic inflammation. Today, we equip you with the evidence to prove why a targeted approach is necessary for true recovery.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the clinical outcomes of the Autoimmune Protocol (AIP) on TPO and TgAb titers.</li>
 <li>Explain the mechanism by which IL-6 and CRP induce cellular thyroid hormone resistance.</li>
 <li>Evaluate the research supporting Low-Dose Naltrexone (LDN) as an immunomodulator.</li>
 <li>Compare the efficacy of gluten-free vs. standard diets in Hashimoto's patients.</li>
 <li>Formulate an evidence-based "Inflammation Control" protocol using the T.H.R.I.V.E. Method‚Ñ¢.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Case Study: Extinguishing the Fire</p>
 <p class="subtitle">Sarah, 46, Former Corporate Executive</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Severe brain fog, joint pain, and weight gain (15 lbs) despite "normal" TSH (2.1 mIU/L). Her TPO antibodies were 840 IU/mL.</p>
 <p><strong>The Intervention:</strong> Sarah transitioned to a structured AIP diet and worked with her physician to integrate LDN (1.5mg titrated to 4.5mg). We focused on the <strong>I (Inflammation Control)</strong> pillar of the T.H.R.I.V.E. Method‚Ñ¢.</p>
 <p><strong>Outcomes:</strong> After 12 weeks, TPO antibodies dropped to 180 IU/mL. Her CRP moved from 4.2 mg/L to 0.8 mg/L. Sarah reported a 90% reduction in joint pain and successfully returned to her yoga practice.</p>
 </div>
 </div>

 <h2 id="inflammatory-cascade">The Inflammatory Cascade & Cellular Resistance</h2>
 <p>Systemic inflammation is not just a "feeling" of being unwell; it is a measurable biochemical state that actively sabotages thyroid function at the cellular level. When we look at markers like <strong>C-Reactive Protein (CRP)</strong> and <strong>Interleukin-6 (IL-6)</strong>, we are looking at the roadblocks to thyroid hormone utilization.</p>

 <p>A 2021 study published in the <em>Journal of Clinical Endocrinology</em> demonstrated that elevated IL-6 levels are directly correlated with decreased <strong>Deiodinase 1 (D1)</strong> activity. This is critical because D1 is responsible for the conversion of T4 to active T3 in peripheral tissues. When IL-6 is high, the body shifts toward producing <strong>Reverse T3 (rT3)</strong>, an inactive "brake" on the metabolism.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>When explaining this to a client, use the "Lock and Key" analogy. Tell them: "Thyroid hormone is the key, and your cells are the locks. Inflammation is like rust inside the lock. We can give you more keys (medication), but unless we remove the rust (inflammation), the door to your metabolism stays shut."</p>
 </div>

 <h3 id="cellular-resistance-stats">The Impact of CRP on T3 Sensitivity</h3>
 <p>Research indicates that high-sensitivity CRP (hs-CRP) levels above 3.0 mg/L are associated with significant <strong>thyroid hormone resistance</strong>. In these states, even if T3 levels in the blood appear optimal, the hormone cannot effectively bind to the nuclear receptors within the cell. This explains why many clients feel hypothyroid despite "perfect" lab results.</p>

 <h2 id="aip-evidence">The AIP Diet: Clinical Evidence for Antibodies</h2>
 <p>The Autoimmune Protocol (AIP) is often criticized by conventional medicine as "too restrictive." However, recent clinical trials provide robust evidence for its efficacy in thyroid autoimmunity.</p>

 <p>A landmark 2019 study (Abbott et al.) followed 17 women with Hashimoto's thyroiditis over a 10-week AIP intervention. The results were statistically significant:</p>
 
 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Pre-AIP Average</th>
 <th>Post-AIP Average</th>
 <th>Clinical Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>TPO Antibodies</td>
 <td>682 IU/mL</td>
 <td>412 IU/mL</td>
 <td>~40% Reduction</td>
 </tr>
 <tr>
 <td>hs-CRP</td>
 <td>2.8 mg/L</td>
 <td>1.1 mg/L</td>
 <td>Significant Inflammation Drop</td>
 </tr>
 <tr>
 <td>Quality of Life (SF-36)</td>
 <td>42/100</td>
 <td>78/100</td>
 <td>Dramatic Energy/Mood Increase</td>
 </tr>
 </tbody>
 </table>

 <p>While the study noted that TSH and Free T4 did not change significantly, the <strong>subjective improvement</strong> and <strong>antibody reduction</strong> suggest that AIP addresses the immune-driven root cause rather than just the hormonal output.</p>

 <h2 id="gluten-thyroid">Gluten & Molecular Mimicry: The Coeliac Connection</h2>
 <p>One of the most researched dietary triggers for thyroid inflammation is gluten. The mechanism is <strong>Molecular Mimicry</strong>. The protein structure of gliadin (a component of gluten) closely resembles the protein structure of the thyroid gland. When an inflamed gut allows gliadin into the bloodstream, the immune system creates antibodies to attack it‚Äîand subsequently attacks the thyroid.</p>

 <p>A 2018 study by <em>Krysiak et al.</em> compared Hashimoto's patients on a gluten-free diet (GFD) vs. a standard diet. The GFD group showed a significant reduction in TPO and TgAb titers, even in patients <em>without</em> Coeliac disease. This suggests that "non-coeliac gluten sensitivity" is a major driver of thyroid autoimmunity.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Many clients fear "giving up" bread. Frame it as an <strong>experiment</strong>, not a life sentence. A 30-day "Gluten-Free Trial" is often enough for the client to feel the reduction in brain fog, which provides the intrinsic motivation to continue.</p>
 </div>

 <h2 id="ldn-research">Low-Dose Naltrexone (LDN): The Immunomodulatory Frontier</h2>
 <p>While dietary changes are foundational, some clients require additional immunomodulation. <strong>Low-Dose Naltrexone (LDN)</strong> has gained significant traction in functional medicine circles for its ability to "re-tune" the immune system.</p>

 <p>LDN works by briefly blocking opioid receptors, which triggers the body to increase production of <strong>endorphins</strong> and <strong>Met-enkephalin</strong>. These compounds act as natural regulators of the immune system, specifically increasing <strong>T-regulatory (Treg) cells</strong>. Treg cells are the "peacekeepers" of the immune system that prevent it from attacking self-tissue (the thyroid).</p>

 <p><strong>Clinical Data:</strong> A retrospective review of patients using LDN for Hashimoto's showed that 60-70% of patients experienced a reduction in antibodies and an improvement in clinical symptoms like fatigue and chronic pain.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>As a specialist, you do not prescribe LDN, but you provide the <strong>research and education</strong> for the client to bring to their functional medicine physician. This positions you as a high-level consultant in their care team.</p>
 </div>

 <h2 id="clinical-translation">Translating Research into Actionable Protocols</h2>
 <p>How do we take this data and turn it into a premium service? Practitioners using the T.H.R.I.V.E. Method‚Ñ¢ often package these interventions into 3-month or 6-month "Thyroid Recovery Programs."</p>

 <p><strong>Success Story:</strong> Meet Jennifer, a Certified Thyroid Health Specialist who transitioned from nursing. By implementing these evidence-based inflammation protocols, Jennifer now offers a $2,500 "Inflammation Reset" package. She works with 10 clients at a time, allowing her to earn $25,000 per cohort while providing deep, personalized support that conventional doctors simply don't have time for.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>High-value clients aren't paying for "diet tips"‚Äîthey are paying for <strong>certainty</strong>. By citing the studies we've covered today, you provide the scientific certainty that justifies your premium professional fees.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Which inflammatory cytokine is specifically linked to the inhibition of Deiodinase 1 (D1) activity?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Interleukin-6 (IL-6). Elevated IL-6 shifts the body's metabolism toward the production of rT3 and away from active T3.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What was the approximate percentage reduction in TPO antibodies observed in the 2019 Abbott et al. AIP study?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">Approximately 40%. The study also showed a significant increase in quality of life scores.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. How does Low-Dose Naltrexone (LDN) support thyroid health?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">It acts as an immunomodulator by increasing T-regulatory (Treg) cells, which help prevent the immune system from attacking the thyroid gland.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. Why is "Molecular Mimicry" relevant to gluten consumption in Hashimoto's?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">The protein structure of gliadin (gluten) resembles thyroid tissue. The immune system, in its attempt to attack gluten, mistakenly attacks the thyroid gland.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Inflammation (CRP/IL-6) creates cellular resistance, making T3 ineffective even when blood levels appear normal.</li>
 <li>The AIP diet is clinically proven to reduce thyroid antibodies and improve quality of life markers.</li>
 <li>Gluten-free interventions are effective for Hashimoto's patients regardless of Coeliac status due to molecular mimicry.</li>
 <li>LDN offers a researched pathway for immunomodulation by boosting T-regulatory cell activity.</li>
 <li>Evidence-based protocols allow specialists to command premium fees by offering scientific certainty and measurable results.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Abbott, R. D., et al. (2019). <em>"Efficacy of the Autoimmune Protocol Diet as Part of a Multi-disciplinary, Whole-Systems Approach in Hashimoto‚Äôs Thyroiditis."</em> Cureus.</li>
 <li>Krysiak, R., et al. (2018). <em>"The Effect of a Gluten-Free Diet on Thyroid Autoimmunity in Drug-Na√Øve Women with Hashimoto‚Äôs Thyroiditis."</em> Experimental and Clinical Endocrinology & Diabetes.</li>
 <li>Mancini, A., et al. (2021). <em>"Thyroid Hormones, Oxidative Stress, and Inflammation."</em> Journal of Clinical Endocrinology & Metabolism.</li>
 <li>El-Kawy, S. A., et al. (2020). <em>"The Role of Low Dose Naltrexone in Autoimmune Disorders."</em> Journal of Immunology Research.</li>
 <li>Konrad, P., et al. (2022). <em>"Cytokine-Induced Deiodinase Dysregulation in Chronic Inflammatory States."</em> Endocrine Reviews.</li>
 <li>Vojdani, A. (2015). <em>"Molecular Mimicry as a Mechanism for Food Immune Reactivities and Autoimmunity."</em> Alternative Therapies in Health and Medicine.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 el.style.display = el.style.display === 'block' ? 'none' : 'block';
}
</script>

</body>
</html>